Related Experiment Video
Updated: Jun 5, 2026

05:39
Spontaneous Murine Model of Anaplastic Thyroid Cancer
Published on: February 3, 2023
Targeted therapies and thyroid cancer: an update
Christelle de la Fouchardiere1, Jean-Pierre Droz
1Claude Bernard University, Lyon I, Centre Leon Berard, Lyon, France. delafo@lyon.fnclcc.fr
Anti-Cancer Drugs
|January 5, 2011
Summary
Targeted therapies offer new hope for progressive thyroid cancer. Recent advances show benefits in differentiated and medullary types, with emerging success in undifferentiated thyroid carcinoma.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Thyroid cancer treatment has advanced with new targeted therapies.
- Understanding of thyroid cancer development and targets has improved.
- Targeted therapies have shown promise in specific thyroid cancer subtypes.
Purpose of the Study:
- To review targeted therapies for thyroid cancer.
- To discuss recent advances in treating metastatic and progressive thyroid cancer.
- To highlight therapeutic progress in differentiated, medullary, and undifferentiated thyroid carcinomas.
Main Methods:
- Literature review of targeted therapies in thyroid cancer.
- Analysis of clinical trial data for various thyroid cancer types.
- Synthesis of current knowledge on tumor and endothelial targets.
Main Results:
- Targeted therapies have demonstrated efficacy in refractory differentiated and medullary thyroid carcinomas.
- Recent advancements show potential benefits in undifferentiated thyroid carcinoma.
- Progress has been made in identifying and targeting specific molecular pathways.
Conclusions:
- Targeted therapies represent a significant evolution in managing advanced thyroid cancer.
- These approaches offer new hope for patients with refractory and progressive disease.
- Continued research is crucial for expanding effective targeted treatments across all thyroid cancer subtypes.
Related Concept Videos
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Synthesis and Regulation of Thyroid Hormones
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...

